Westfield Capital Management Co. LP Buys 94,129 Shares of IDEXX Laboratories

The institutional investor now owns 0.12% of the veterinary diagnostics company.

Published on Feb. 27, 2026

Westfield Capital Management Co. LP, an institutional investor, purchased a new stake of 94,129 shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) during the third quarter. The shares are valued at approximately $60,138,000, representing 0.12% ownership of the veterinary diagnostics company.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic products and services for the animal health, water testing, and food safety markets. The company's strong performance and growth potential have attracted the attention of institutional investors like Westfield Capital Management.

The details

According to a 13F filing with the Securities and Exchange Commission, Westfield Capital Management Co. LP bought the 94,129 shares of IDEXX Laboratories during the third quarter. This new stake represents 0.12% ownership of the company.

  • Westfield Capital Management Co. LP purchased the shares in the third quarter of the year.

The players

Westfield Capital Management Co. LP

An institutional investor that purchased a new stake of 94,129 shares in IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

A global developer, manufacturer, and provider of diagnostic products and services primarily for the animal health, water testing, and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

The investment by Westfield Capital Management Co. LP in IDEXX Laboratories highlights the company's strong position in the veterinary diagnostics market and its potential for continued growth and success.